ADXN Addex Therapeutics: Business Value

Official company branding of addextherapeutics.com (ADXN)

The financial price chart for Addex Therapeutics (ADXN) demonstrates an enterprise value of 2.32. Addex Therapeutics develops neuropreparations through partnerships with global corporations and the acquisition of patents. Trial stability is ensured by streamlined raw material supply chains from various foreign suppliers. The business relies on the creation of specific receptor modulators, whose exclusive legal protection guarantees the profitability of future medical developments.

ADXN (Addex) Total Company Value history from 11/23/2025 to 10/28/2026

Addex Therapeutics (ADXN) - metric breakdowns and financial figures

- price and consensus price forecast:
Share Price Addex Therapeutics Ltd.|ADXN - Consensus Target
- market capitalization data:
Market Capitalization Addex Therapeutics|ADXN - Total Company Value
- book capitalization data:
Equity per Share Addex Therapeutics|ADXN - Company Book Value|Capitalization to Book Value Ratio addextherapeutics.com|ADXN - Company Total Assets
- debt and liquidity data:
Debt to Capital Addex Therapeutics|ADXN - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital addextherapeutics.com|ADXN - Company Debts|Debt to Net Assets Ratio Addex Therapeutics
Comprehensive company analysis:Addex Therapeutics Ltd. (ADXN)
Mass-produced product of Addex Therapeutics

Enterprise Value (EV) represents the total buyout price of a business, combining market capitalization with net debt to eliminate liquidity distortions. Analyzing the operational value (EV) of Addex Therapeutics allows for the tracking of its actual financial leverage, which is critical while the development of allosteric modulators with global partners is still maturing and not yet generating an immediate cash effect.

Direct competitors

BIIB - Business Value|Neurocrine Biosciences Inc (NBIX) - Real Price to Acquire Entire Company|RGC: Business Value|Total Company Value Axsome Therapeutics|ACAD (acadia-pharm.com) - Business Value|Total Company Value Xenon (XENE)|Business Value Viking Therapeutics Inc|Supernus Pharma - Enterprise Value|Total Enterprise Value Catalyst Corp CPRX|Real Price to Acquire Entire Company DNLI (Denali Therapeutics)|harmonybiosciences.com - Enterprise Value|Total Company Value Biohaven (BHVN)|AMLX: Value Adjusted for Debt and Cash|Total Company Value TRVI|Praxis Corp (PRAX) - Total Enterprise Value|AVXL (Anavex Life Sciences) - Enterprise Value|Enterprise Value ceribell.com|Enterprise Value Prothena Biosciences PRTA|Business Value alector.com (ALEC)|ANNX - Enterprise Value|Business Value Omeros Corp OMER|NGNE (Neurogene Inc.) - Enterprise Value|acimmune.com (ACIU) - Total Enterprise Value|Real Price to Acquire Entire Company Voyager Therapeutics, Inc.|Business Value Neumora|SCLX - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash Tevogen Bio Inc. (TVGN)|Real Price to Acquire Entire Company Alpha Cognition|Aggregate Business Value Cognition Therapeutics Inc. (CGTX)|Enterprise Value Inhibikase Therapeutics, Inc.|Value Adjusted for Debt and Cash Cassava Sciences Inc SAVA|ASRT (Assertio Therapeutics) - Enterprise Value|COYA: Total Enterprise Value|Total Company Value vistagen.com VTGN|Ovid Therapeutics (OVID) - Value Adjusted for Debt and Cash|ABOS (Acumen Pharmaceuticals, Inc.) - Enterprise Value|Enterprise Value CRVO|ATHE - Total Company Value|Full Business Value clene.com (CLNN)|PEPG: Enterprise Value|JUNS - Total Enterprise Value|Relmada Therapeutics, Inc. - Real Price to Acquire Entire Company|Annovis Bio Inc (ANVS) - Enterprise Value|GRCE - Real Price to Acquire Entire Company|Firefly Neuro (AIFF) - Aggregate Business Value|KLTO: Enterprise Value|Company Buyout Price NeuroSense Therapeutics, Ltd.|Enterprise Value RVPH (Reviva Pharmaceuticals Holdings, Inc.)|Real Price to Acquire Entire Company MTVA (metaviatx.com)|Total Company Value NRXS|Company Buyout Price Helius Medical Technologies, Inc. HSDT|Passage Bio Corp - Enterprise Value|NEUP - Enterprise Value|Enterprise Value Minerva Neurosciences, Inc.|Business Value Athira Pharma Inc|Real Price to Acquire Entire Company Alzamend Neuro Inc. (ALZN)|Business Value CYCN|Total Company Value Protagenic Therapeutics PTIX|Business Value KTTA (pasitheaclinics.com)|CRGT - Total Company Value|Business Value Avenue Therapeutics Inc. ATXI|BCLI (Brainstorm Cell Therapeutics, Inc.) - Enterprise Value|Cara Therapeutics Inc (CARA) - Total Enterprise Value|CHRO: Real Price to Acquire Entire Company|ELYM (Eliem Therapeutics Inc.) - Enterprise Value|ITCI - Total Company Value|Value Adjusted for Debt and Cash LBPH|Marinus - Total Company Value|Total Enterprise Value NKGen Biotech Corp (NKGN)|Enterprise Value NRBO (NeuroBo Pharmaceuticals)|Enterprise Value sagerx.com SAGE|Synaptogenix (SNPX) - Enterprise Value|TRVN - Business Value|Enterprise Value vigilneuro.com|anewmeds.com (WENA) - Business Value|Enterprise Value CERE (Cerevel Therapeutics)